FR2726577B1 - Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament - Google Patents

Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament

Info

Publication number
FR2726577B1
FR2726577B1 FR9413309A FR9413309A FR2726577B1 FR 2726577 B1 FR2726577 B1 FR 2726577B1 FR 9413309 A FR9413309 A FR 9413309A FR 9413309 A FR9413309 A FR 9413309A FR 2726577 B1 FR2726577 B1 FR 2726577B1
Authority
FR
France
Prior art keywords
medicaments
polypeptide
obtaining
applications
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9413309A
Other languages
English (en)
Other versions
FR2726577A1 (fr
Inventor
Hans Binz
Ngoc Thien Nguyen
Stefan Stahl
Mathias Uhlen
Per Ake Nygren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9413309A priority Critical patent/FR2726577B1/fr
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to US08/836,504 priority patent/US6130091A/en
Priority to JP8515109A priority patent/JPH10509865A/ja
Priority to AU41201/96A priority patent/AU704703B2/en
Priority to CA002204618A priority patent/CA2204618A1/fr
Priority to ZA959418A priority patent/ZA959418B/xx
Priority to PCT/FR1995/001465 priority patent/WO1996014418A1/fr
Priority to EP95939337A priority patent/EP0789768A1/fr
Priority to NZ296563A priority patent/NZ296563A/en
Publication of FR2726577A1 publication Critical patent/FR2726577A1/fr
Application granted granted Critical
Publication of FR2726577B1 publication Critical patent/FR2726577B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9413309A 1994-11-07 1994-11-07 Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament Expired - Fee Related FR2726577B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR9413309A FR2726577B1 (fr) 1994-11-07 1994-11-07 Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament
JP8515109A JPH10509865A (ja) 1994-11-07 1995-11-07 細菌膜上で発現される呼吸器多核体ウイルスプロテインｇ
AU41201/96A AU704703B2 (en) 1994-11-07 1995-11-07 Respiratory syncytial virus protein G expressed on bacterial membrane
CA002204618A CA2204618A1 (fr) 1994-11-07 1995-11-07 Proteine g du virus respiratoire syncytial exprimee sur membrane bacterienne
US08/836,504 US6130091A (en) 1994-11-07 1995-11-07 Method for obtaining a peptide derived from the respiratory syncytial virus polypeptide and bacterium expressing it
ZA959418A ZA959418B (en) 1994-11-07 1995-11-07 Method for obtaining a peptide derived from the respiratory syncytial virus polypeptide and bacterium expressing it and their applications as medicinal products
PCT/FR1995/001465 WO1996014418A1 (fr) 1994-11-07 1995-11-07 Proteine g du virus respiratoire syncytial exprimee sur membrane bacterienne
EP95939337A EP0789768A1 (fr) 1994-11-07 1995-11-07 Proteine g du virus respiratoire syncytial exprimee sur membrane bacterienne
NZ296563A NZ296563A (en) 1994-11-07 1995-11-07 Fusion proteins, conjunction with proteins from respiratory syncytial virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9413309A FR2726577B1 (fr) 1994-11-07 1994-11-07 Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament

Publications (2)

Publication Number Publication Date
FR2726577A1 FR2726577A1 (fr) 1996-05-10
FR2726577B1 true FR2726577B1 (fr) 1997-01-31

Family

ID=9468567

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9413309A Expired - Fee Related FR2726577B1 (fr) 1994-11-07 1994-11-07 Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament

Country Status (9)

Country Link
US (1) US6130091A (fr)
EP (1) EP0789768A1 (fr)
JP (1) JPH10509865A (fr)
AU (1) AU704703B2 (fr)
CA (1) CA2204618A1 (fr)
FR (1) FR2726577B1 (fr)
NZ (1) NZ296563A (fr)
WO (1) WO1996014418A1 (fr)
ZA (1) ZA959418B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
US6699478B1 (en) 1997-09-19 2004-03-02 Wyeth Holdings Corporation Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus
KR100550132B1 (ko) * 1997-09-19 2006-02-08 와이어쓰 홀딩스 코포레이션 호흡 신시티아 바이러스의 부착 (지) 단백질에서 유도된펩티드
FR2798857B1 (fr) * 1999-09-23 2003-06-06 Pf Medicament Utilisation d'une proteine de membrane ompa d'enterobacterie associee a un peptide immunogene du vrs pour la preparation de vaccins administrables par voie nasale
EP2503008B1 (fr) 2007-04-19 2015-04-01 Molecular Detection Inc. Méthodes, compositions et kits de détection et d'analyse de bacteries resistantes aux antibiotiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149650A (en) * 1986-01-14 1992-09-22 University Of North Carolina At Chapel Hill Vaccines for human respiratory virus
AU605476B2 (en) * 1986-01-14 1991-01-17 University Of North Carolina, The Vaccines for human respiratory virus
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
SE9101433D0 (sv) * 1991-05-13 1991-05-13 Marianne Hansson Recombinant dna sequence and its use

Also Published As

Publication number Publication date
AU704703B2 (en) 1999-04-29
CA2204618A1 (fr) 1996-05-17
FR2726577A1 (fr) 1996-05-10
AU4120196A (en) 1996-05-31
JPH10509865A (ja) 1998-09-29
EP0789768A1 (fr) 1997-08-20
ZA959418B (en) 1996-06-06
WO1996014418A1 (fr) 1996-05-17
US6130091A (en) 2000-10-10
NZ296563A (en) 1999-04-29

Similar Documents

Publication Publication Date Title
TR199600786T1 (tr) Agiz yoluyla alinan yeni farmasötik dozaj formlari.
GB2303064B (en) Medicament for nasal administration
HK1018012A1 (en) Inhaler for administering medicaments from blisterpacks
MA26685A1 (fr) Derives d'azetidine leur preparation et les medicaments les contenant
IL127714A0 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders
FR2722788B1 (fr) Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
PL354322A1 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
HRP20010115B1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
FR2671086B1 (fr) Peptides opiouides, leur procede de preparation, et composition pharmaceutique contenant ces peptides.
GB9418064D0 (en) Medicament administration inhaler
AU6926496A (en) New cyclic guanidines, process for preparing the same and medicaments
ZA966313B (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them.
FR2726577B1 (fr) Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament
DE69918961D1 (de) Verbesserte inhalationspräparate
ZA916638B (en) Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type,a process for their preparation and their use as medicaments against retroviruses
HU9700989D0 (en) Ortho-substituted benzoyl-guanidines, process for producing them, their use as medicament and diagnosticment, pharmaceutical compositions containing them
HUP9702395A3 (en) Prokinetic oxadiazoles, process for their preparation, intermediates and pharmaceutical compositions containing the same
GR3035710T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds as well as medicaments containing them
SI0754680T1 (en) 4-Fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as medicament as well as medicaments containing them
KR960701075A (ko) 신규 2'-메틸리덴 뉴클레오티드 화합물, 그의 제조 방법 및 그의 약학적 용도[novel 2'-methylidenenucleotide compound, process for producing the same, and pharmaceutical use thereof]
FR2687155B1 (fr) Nouveaux derives hexapeptidiques, procede de preparation et application a titre de medicaments de ces nouveaux derives.
FI963753A (fi) Uusi lääke hengitysteiden virustaudin hoitamiseksi
SI0778025T1 (en) Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals
FR2661180B1 (fr) (hydroxyproline 9) lhrh, son procede d'obtention et application comme medicament.
FR2680369B1 (fr) Derives d'hemoglobine humaine, leur procede de preparation, produits en derivant et utilisation de ces derives et produits.

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse